Epigenetic Alterations in Acute Kidney Injury

Seminars in Nephrology

Volumn 33, Issue 4, 2013, Pages 327-340

  Bomsztyk, Karol ^a   Denisenko, Oleg ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acute kidney injury; Chromatin; DNA methylation; Epigenetics; Histone modification

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGININE; BETA ACTIN; BRG1 PROTEIN; CURCUMIN; DEXMEDETOMIDINE; DNA; ENTINOSTAT; HEME OXYGENASE 1; HISTONE; LYSINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTECTIVE AGENT; RESVERATROL; SRT 1720; SRT 2183; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT;

ACUTE KIDNEY FAILURE; AMINO ACID SUBSTITUTION; ARTICLE; BRG1 GENE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTONE ACETYLATION; HUMAN; IMMUNOPRECIPITATION; KIDNEY DISEASE; MCP 1 GENE; METHYLATED DNA IMMUNOPRECIPITATION; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEOSOME; NUCLEOSOME REMODELING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RENAL PROTECTION; TNF ALPHA GENE;

ACUTE KIDNEY INJURY; CHROMATIN; DNA METHYLATION; EPIGENETICS; HISTONE MODIFICATION;

ACETYLATION; ACUTE KIDNEY INJURY; ANIMALS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84883543223     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2013.05.005     Document Type: Article

References (106)

1. Bonventre J.V., Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011, 121:4210-4221.
2. Chertow G.M., Burdick E. Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370.
3. Coca S.G. Long-term outcomes of acute kidney injury. Curr Opin Nephrol Hypertens 2010, 19:266-272.
4. Kelly K.J. Acute renal failure: much more than a kidney disease. Semin Nephrol 2006, 26:105-113.
5. Murugan R., Kellum J.A. Acute kidney injury: what's the prognosis?. Nat Rev Nephrol 2011, 7:209-217.
6. Akcay A., Nguyen Q., Edelstein C.L. Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009, 2009:137072.
7. Nath K.A. Renal response to repeated exposure to endotoxin: implications for acute kidney injury. Kidney Int 2007, 71:477-479.
8. Zager R.A., Johnson A.C., Hanson S.Y., Lund S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release. Am J Physiol Renal Physiol 2005, 289:F289-F297.
9. Zager R.A., Johnson A.C., Hanson S.Y., Lund S. Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/chemokine production. Kidney Int 2006, 69:1181-1188.
10. Zager R.A., Johnson A.C., Lund S. 'Endotoxin tolerance': TNF-alpha hyper-reactivity and tubular cytoresistance in a renal cholesterol loading state. Kidney Int 2007, 71:496-503.
11. Ptashne M. On the use of the word 'epigenetic'. Curr Biol 2007, 17:R233-R236.
12. Berger S.L., Kouzarides T., Shiekhattar R., Shilatifard A. An operational definition of epigenetics. Genes Dev 2009, 23:781-783.
13. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
14. Musselman C.A., Lalonde M.E., Cote J., Kutateladze T.G. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol 2012, 19:1218-1227.
15. McBryant S.J., Lu X., Hansen J.C. Multifunctionality of the linker histones: an emerging role for protein-protein interactions. Cell Res 2010, 20:519-528.
16. Belkina A.C., Denis G.V. BET domain co-regulators in obesity, inflammation and cancer. Nat Rev Cancer 2012, 12:465-477.
17. Nelson J.D., Denisenko O., Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 2006, 1:179-185.
18. Millar D.S., Warnecke P.M., Melki J.R., Clark S.J. Methylation sequencing from limiting DNA: embryonic, fixed, and microdissected cells. Methods 2002, 27:108-113.
19. Yu J., Feng Q., Ruan Y., Komers R., Kiviat N., et al. Microplate-based platform for combined chromatin and DNA methylation immunoprecipitation assays. BMC Mol Biol 2011, 12:49.
20. Dekker J., Rippe K., Dekker M., Kleckner N. Capturing chromosome conformation. Science 2002, 295:1306-1311.
21. Naito M., Zager R.A., Bomsztyk K. BRG1 increases transcription of proinflammatory genes in renal ischemia. J Am Soc Nephrol 2009, 20:1787-1796.
22. Kim J., Zarjou A., Traylor A.M., Bolisetty S., Jaimes E.A., et al. In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice. Kidney Int 2012, 82:278-291.
23. Nelson J.D., Denisenko O., Sova P., Bomsztyk K. Fast chromatin immunoprecipitation assay. Nucleic Acids Res 2006, 34:e2.
24. Huebert D.J., Kamal M., O'Donovan A., Bernstein B.E. Genome-wide analysis of histone modifications by ChIP-on-chip. Methods 2006, 40:365-369.
25. Johnson D.S., Mortazavi A., Myers R.M., Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502.
26. Li G., Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev 2011, 21:175-186.
27. Johnson A.B., Barton M.C. Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutat Res 2007, 618:149-162.
28. Bell A.C., West A.G., Feisenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 1999, 98:387-396.
29. Mellor J. Dynamic nucleosomes and gene transcription. Trends Genet 2006, 22:320-329.
30. Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008, 132:887-898.
31. Belotserkovskaya R., Oh S., Bondarenko V.A., Orphanides G., Studitsky V.M., et al. FACT facilitates transcription-dependent nucleosome alteration. Science 2003, 301:1090-1093.
32. Bultman S., Gebuhr T., Yee D., La Mantia C., Nicholson J., et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 2000, 6:1287-1295.
33. Kim S.I., Bresnick E.H., Bultman S.J. BRG1 directly regulates nucleosome structure and chromatin looping of the {alpha} globin locus to activate transcription. Nucleic Acids Res 2009, 37:6019-6027.
34. Naito M., Bomsztyk K., Zager R.A. Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. J Am Soc Nephrol 2008, 19:1321-1330.
35. Naito M., Bomsztyk K., Zager R.A. Renal ischemia-induced cholesterol loading: transcription factor recruitment and chromatin remodeling along the HMG CoA reductase gene. Am J Pathol 2009, 174:54-62.
36. Zager R.A., Johnson A.C. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol 2009, 296:F1032-F1041.
37. Portela A., Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010, 28:1057-1068.
38. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
39. Patra S.K., Patra A., Rizzi F., Ghosh T.C., Bettuzzi S. Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metastasis Rev 2008, 27:315-334.
40. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416:552-556.
41. Yoo C.B., Jones P.A. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006, 5:37-50.
42. Chen Z.X., Riggs A.D. DNA methylation and demethylation in mammals. J Biol Chem 2011, 286:18347-18353.
43. Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448:714-717.
44. Fournier A., Sasai N., Nakao M., Defossez P.A. The role of methyl-binding proteins in chromatin organization and epigenome maintenance. Brief Funct Genomics 2012, 11:251-264.
45. Kangaspeska S., Stride B., Metivier R., Polycarpou-Schwarz M., Ibberson D., et al. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
46. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
47. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
48. Guo J.U., Su Y., Zhong C., Ming G.L., Song H. Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond. Cell Cycle 2011, 10:2662-2668.
49. Globisch D., Munzel M., Muller M., Michalakis S., Wagner M., et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 2010, 5:e15367.
50. Pratt J.R., Parker M.D., Affleck L.J., Corps C., Hostert L., et al. Ischemic epigenetics and the transplanted kidney. Transplant Proc 2006, 38:3344-3346.
51. Mehta T.K., Hoque M.O., Ugarte R., Rahman M.H., Kraus E., et al. Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation. Transplant Proc 2006, 38:3420-3426.
52. Huang N., Tan L., Xue Z., Cang J., Wang H. Reduction of DNA hydroxymethylation in the mouse kidney insulted by ischemia reperfusion. Biochem Biophys Res Commun 2012, 422:697-702.
53. Allis C.D., Berger S.L., Cote J., Dent S., Jenuwien T., et al. New nomenclature for chromatin-modifying enzymes. Cell 2007, 131:633-636.
54. Cheutin T., McNairn A.J., Jenuwein T., Gilbert D.M., Singh P.B., et al. Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science 2003, 299:721-725.
55. Trotter K.W., Archer T.K. The BRG1 transcriptional coregulator. Nucl Recept Signal 2008, 6:e004.
56. Yuan H., Marmorstein R. Histone acetyltransferases: rising ancient counterparts to protein kinases. Biopolymers 2013, 99:98-111.
57. Flanagin S., Nelson J.D., Castner D.G., Denisenko O., Bomsztyk K. Microplate-based chromatin immunoprecipitation method, Matrix ChIP: a platform to study signaling of complex genomic events. Nucleic Acids Res 2008, 36:e17.
58. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., et al. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 2003, 983:84-100.
59. Li H.L., Liu C. de Couto G, Ouzounian M, Sun M, et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008, 118:879-893.
60. Hellebrekers D.M., Griffioen A.W., van Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta 2007, 1775:76-91.
61. Marumo T., Hishikawa K., Yoshikawa M., Fujita T. Epigenetic regulation of BMP7 in the regenerative response to ischemia. J Am Soc Nephrol 2008, 19:1311-1320.
62. Li H.F., Cheng C.F., Liao W.J., Lin H., Yang R.B. ATF3-mediated epigenetic regulation protects against acute kidney injury. J Am Soc Nephrol 2010, 21:1003-1013.
63. Hsing C.H., Lin C.F., So E., Sun D.P., Chen T.C., et al. alpha2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Am J Physiol Renal Physiol 2012, 303:F1443-F1453.
64. Marumo T., Hishikawa K., Yoshikawa M., Hirahashi J., Kawachi S., et al. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 2010, 298:F133-F141.
65. Havasi A., Haegele J.A., Gall J.M., Blackmon S., Ichimura T., et al. Histone acetyl transferase (HAT) HBO1 and JADE1 in epithelial cell regeneration. Am J Pathol 2013, 182:152-162.
66. Zager R.A., Johnson A.C., Becker K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease. Am J Physiol Renal Physiol 2011, 301:F1334-F1345.
67. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002, 16:695-714.
68. Brilli L.L., Swanhart L.M., de Caestecker M.P., Hukriede N.A. HDAC inhibitors in kidney development and disease. Pediatr Nephrol 2012, Epub ahead of print.
69. Zacharias N., Sailhamer E.A., Li Y., Liu B., Butt M.U., et al. Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells. Resuscitation 2011, 82:105-109.
70. Van Beneden K., Geers C., Pauwels M., Mannaerts I., Verbeelen D., et al. Valproic acid attenuates proteinuria and kidney injury. J Am Soc Nephrol 2011, 22:1863-1875.
71. Liu N., He S., Ma L., Ponnusamy M., Tang J., et al. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS One 2013, 8:e54001.
72. Imai N., Hishikawa K., Marumo T., Hirahashi J., Inowa T., et al. Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury. Stem Cells 2007, 25:2469-2475.
73. He W., Wang Y., Zhang M.Z., You L., Davis L.S., et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 2010, 120:1056-1068.
74. Zager R.A., Johnson A.C., Naito M., Lund S.R., Kim N., et al. Growth and development alter susceptibility to acute renal injury. Kidney Int 2008, 74:674-678.
75. Fan H., Yang H.C., You L., Wang Y.Y., He W.J., et al. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int 2013, 83:404-413.
76. Hargreaves D.C., Horng T., Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009, 138:129-145.
77. Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., et al. Selective inhibition of BET bromodomains. Nature 2010, 468:1067-1073.
78. Nicodeme E., Jeffrey K.L., Schaefer U., Beinke S., Dewell S., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-1123.
79. Zhou H., Beevers C.S., Huang S. The targets of curcumin. Curr Drug Targets 2011, 12:332-347.
80. Balasubramanyam K., Varier R.A., Altaf M., Swaminathan V., Siddappa N.B., et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004, 279:51163-51171.
81. Memis D., Hekimoglu S., Sezer A., Altaner S., Sut N., et al. Curcumin attenuates the organ dysfunction caused by endotoxemia in the rat. Nutrition 2008, 24:1133-1138.
82. Kuhad A., Pilkhwal S., Sharma S., Tirkey N., Chopra K. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem 2007, 55:10150-10155.
83. Bayrak O., Uz E., Bayrak R., Turgut F., Atmaca A.F., et al. Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J Urol 2008, 26:285-291.
84. Mueller D., Garcia-Cuellar M.P., Bach C., Buhl S., Maethner E., et al. Misguided transcriptional elongation causes mixed lineage leukemia. PLoS Biol 2009, 7:e1000249.
85. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007, 39:311-318.
86. Kooistra S.M., Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 2012, 13:297-311.
87. Santos-Rosa H., Schneider R., Bannister A.J., Sherriff J., Bernstein B.E., et al. Active genes are tri-methylated at K4 of histone H3. Nature 2002, 419:407-411.
88. Keogh M.C., Kurdistani S.K., Morris S.A., Ahn S.H., Podolny V., et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 2005, 123:593-605.
89. Venkatesh S., Smolle M., Li H., Gogol M.M., Saint M., et al. Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes. Nature 2012, 489:452-455.
90. Kizer K.O., Phatnani H.P., Shibata Y., Hall H., Greenleaf A.L., et al. A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with transcript elongation. Mol Cell Biol 2005, 25:3305-3316.
91. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 2006, 75:243-269.
92. Okada Y., Feng Q., Lin Y., Jiang Q., Li Y., et al. hDOT1L links histone methylation to leukemogenesis. Cell 2005, 121:167-178.
93. Munshi R., Johnson A., Siew E.D., Ikizler T.A., Ware L.B., et al. MCP-1 gene activation marks acute kidney injury. J Am Soc Nephrol 2011, 22:165-175.
94. Banerjee T., Chakravarti D. A peek into the complex realm of histone phosphorylation. Mol Cell Biol 2011, 31:4858-4873.
95. Zippo A., Serafini R., Rocchigiani M., Pennacchini S., Krepelova A., et al. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009, 138:1122-1136.
96. Hake S.B., Allis C.D. Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis.". Proc Natl Acad Sci U S A 2006, 103:6428-6435.
97. Kirmizis A., Santos-Rosa H., Penkett C.J., Singer M.A., Vermeulen M., et al. Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 2007, 449:928-932.
98. Workman J.L. Nucleosome displacement in transcription. Genes Dev 2006, 20:2009-2017.
99. Talbert P.B., Ahmad K., Almouzni G., Ausio J., Berger F., et al. A unified phylogeny-based nomenclature for histone variants. Epigenetics Chromatin 2012, 5:7.
100. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
101. John S., Sabo P.J., Johnson T.A., Sung M.H., Biddie S.C., et al. Interaction of the glucocorticoid receptor with the chromatin landscape. Mol Cell 2008, 29:611-624.
102. Wirbelauer C., Bell O., Schubeler D. Variant histone H3.3 is deposited at sites of nucleosomal displacement throughout transcribed genes while active histone modifications show a promoter-proximal bias. Genes Dev 2005, 19:1761-1766.
103. Burgers W.A., Fuks F., Kouzarides T DNA methyltransferases get connected to chromatin. Trends Genet 2002, 18:275-277.
104. Conerly M.L., Teves S.S., Diolaiti D., Ulrich M., Eisenman R.N., et al. Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis. Genome Res 2010, 20:1383-1390.
105. Azmi A.S., Wang Z., Philip P.A., Mohammad R.M., Sarkar F.H. Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations. Mol Cancer Ther 2010, 9:3137-3144.
106. Gomez D., Shankman L.S., Nguyen A.T., Owens G.K. Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods 2013, 10:171-177.